STEMVAC (NCT05242965), a multiple antigen DNA vaccine, containing five proteins (CDH3, SOX2, YB-1, MDM2 and CD105), was injected into NSCLC patients along with GM-CSF. This evidence concerns the gene YBX1 and non-small cell lung carcinoma.